Evaluation of the Relationship Between Stage I-II Breast Cancer Subtypes and Soluble Immune Checkpoints including PD-1, TIM-3, LAG-3 PD-L1 and Gal-9. This evidence concerns the gene HAVCR2 and breast cancer.